Product Information
CEPHALEXIN 500 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.1200 per EA under NDC 62135071174. Its NADAC has been published 173 times since Jun 14, 2023.
FDA first approved this application on Dec 20, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Chartwell RX LLCNDC
62135071174
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEPHALEXINApproval Type
Generic (ANDA)
FDA Application
ANDA090836FDA Approved
12/20/2010
TE Code
AB
On Market Since
1/19/2011
Pharmacological Classes
Price Statistics
The NADAC for CEPHALEXIN 500 MG CAPSULE has been published 173 times since Jun 14, 2023, and over the history we have for it it has declined 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1200 per EA |
|---|---|
| All-time high | $0.1576 (Jan 10, 2024) |
| All-time low | $0.0897 (Nov 20, 2024) |
| 52-week high | $0.1281 |
| 52-week low | $0.1200 |
| Median price | $0.1270 |
| Average price | $0.1268 |
| Largest weekly change | -30.2% (Nov 20, 2024) |
| Weeks tracked | 173 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cephalexin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cephalexin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEPHALEXIN 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 500 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.1200 per EA (NDC 62135071174), effective Sep 30, 2026.
How has the price of CEPHALEXIN 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEPHALEXIN 500 MG CAPSULE has declined 5.7%. It has been tracked across 173 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for CEPHALEXIN 500 MG CAPSULE?
Since Jun 14, 2023, the NADAC for CEPHALEXIN 500 MG CAPSULE has ranged from a low of $0.0897 (Nov 20, 2024) to a high of $0.1576 (Jan 10, 2024), with a median of $0.1270 per EA.
Are there cheaper alternatives to CEPHALEXIN 500 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of CEPHALEXIN 500 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEPHALEXIN 500 MG CAPSULE?
CEPHALEXIN 500 MG CAPSULE (NDC 62135071174) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.